University of Ioannina
Μελέτη κλινικών και εργαστηριακών δεικτών του μεταβολικού συνδρόμου σε παιδιά και εφήβους με αυξημένο σωματικό βάρος
Abstract
dc:descriptionIn his Banting Lecture in 1988, Gerald Reaven suggested that three major conditions –type 2 diabetes mellitus (DM2), hypertension and coronary artery disease- must have a common underlying pathomechanism, namely the resistance to insulin-stimulated glucose uptake and the resultant hyperinsulinemia. Since that time, this construct has evolved conceptually and functionally into an entity that many refer to as the Metabolic Syndrome (MS). Several scientific groups have tried to define the MS in adults as well as in children and adolescents. In addition, a vast number of papers have been published in an attempt to clarify the roots of the syndrome, its components and its possible ramifications later in life. Parallel to the obesity pandemic in children and adolescents what became gradually clear was that the MS and its components are already present in obese children since the early years of childhood, predisposing them to DM2 and cardiovascular disease (CVD). Since a universally accepted definition of the syndrome in children and adolescents does not exist and since its pathophysiology and consequences have not been fully elucidated, it is important to seek components of the syndrome in obese children that could help in its early diagnosis. The objective of this study was 3-fold: to detect in obese children and adolescents (through their comparison with lean counterparts) primary and secondary abnormalities identified in adults with the MS; to look for laboratory indices that could help in an early diagnosis of the syndrome in obese children; to determine the prevalence of the MS in obese children and adolescents of northwestern Greece. The present study included 103 obese children and adolescents, 5 to 16 years of age (mean: 11,3±2,9 years), that presented to the University Hospital of Ioannina, Ioannina, Greece, with primary obesity (any cause of secondary obesity was excluded). These children went through a thorough physical examination and blood was drawn for basic labs and more specific lab measurements. In addition, an oral glucose tolerance test (OGTT) was performed for every obese child. Obese children were compared to a control group which comprised 69 healthy children and adolescents for whom, a physical was performed and blood was drawn in the same manner (except for the OGTT). The results of this study show that obese children frequently present the major and some of the secondary components of the MS and thus are at increased risk for its complications. More specifically, regarding the physical measurements, obese children had a statistically significantly higher waist circumference, hip circumference, and waist-to-hip and waist-to-height ratio. In addition, skinfold thickness that was measured in biceps, triceps, subscapular and abdominal areas, showed a statistically significant increase in obese children compared to their lean counterparts. Regarding blood pressure (BP), both systolic and diastolic BP were statistically significantly higher in obese children compared to controls. This statistical difference was more important for systolic BP. In addition, obese boys presented with statistically significantly higher systolic BP compared to obese girls. Glucose handling abnormalities included higher insulin resistance (higher HOMA index) and hyperinsulinemia in obese children compared to controls. There was no statistically significant difference in fasting glucose levels between the two groups. In addition, eight out of the 103 obese children presented with IFG, seven had IGT in OGTT, one had both IFG and IGT and one was diagnosed with DM2. Among the control group, one child had IFG. Regarding lipid metabolism, obese children had statistically significantly lower HDL cholesterol and higher triglycerides compared to controls, while no statistically significant difference in total or LDL cholesterol was found. In addition, obese children had lower levels of the protective apolipoprotein apoAI and higher levels of the atherogenic apoB compared to controls. Regarding the secondary characteristics of the MS, obese children and adolescents presented with a prothrombotic and proinflammatory condition. More specifically, both CRP and ESR were statistically significantly higher in obese children, even if their mean value was within the normal limits. The same was true for fibrinogen. In addition, among the hepatic enzymes that were measured, ALT and GGT were statistically significantly higher in obese children and especially in obese boys. This finding suggests an early liver involvement in obese children with characteristics of the MS. Microalbumin was measured in a first morning spot urine sample but showed no significant difference between the two groups. Finally, uric acid was statistically significantly higher in obese children compared to controls. Special lab parameters measured included leptin, IL-6, adiponectin, visfatin as well as plasma renin activity (PRA) and aldosterone...
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Serbis, Anastasios
- Σέρμπης, Αναστάσιος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18254